National Community Pharmacists Association
FDARulemakingFDA-2015-D-3517

Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the FD&C Act

RIN
Last modified
Feb 7, 2025
Comment window
closed 932d ago
National Community Pharmacists Association filings
2

Activity

National Community Pharmacists Association filed 2 comments on this docket between Jan 5, 2016 and Dec 28, 2023. 8 other organizations filed here. The comment window closed 932d ago.

What National Community Pharmacists Association filed (2)

Dec 28, 2023· Comment from National Community Pharmacists Association· FDA-2015-D-3517-0024

NCPA represents America's community pharmacists, including 19,400 independent community pharmacies. Almost half of all community pharmacies provide long-term care services and play a critical role in ensuring patients have immediate access to medications in both community and long-term care (LTC) settings. Together, our members represent a $94 billion healthcare marketplace, employ 230,000 individuals, and provide an expanding set of healthcare services to millions of patients every day. Our members are small business owners who are among America's most accessible healthcare providers. NCPA submits these comments on behalf of both community and LTC independent pharmacies. Our full comments are attached.

Jan 5, 2016· Comment from National Community Pharmacists Association (NCPA)· FDA-2015-D-3517-0011

Attached please find comments submitted by the National Community Pharmacists Association (NCPA).

Abstract

No abstract recorded.

View on regulations.gov →